It is not clear, whether the conclusion also holds for CD28 costimulated CAR T cells as canonical CD28 CAR T cells display higher IL-2 production and tumor control in response to CD19low leukemia compared to 4-1BB-costimulated ζζ CAR T cells (34). The gene discussed is CD28; the disease is neoplasm.